A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Eastern Cooperative Oncology Group
Children's Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Children's Oncology Group
SWOG Cancer Research Network
SWOG Cancer Research Network
SWOG Cancer Research Network
Cooperative Study Group A for Hematology
Cooperative Study Group A for Hematology